Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Journal
Type
Date
Availability
1-2 of 2
Keywords: Value chain
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
A systematic review of UTAUT2 constructs’ analysis among MSMEs in non-OECD countries
Available to Purchase
Journal of Science and Technology Policy Management (2024) 15 (4): 765–793.
Published: 28 February 2023
...-organisation for economic co-operation and development (OECD) countries. It also investigates the areas of ICT adoption along the value chain in studies using these constructs. Design/methodology/approach Systematic literature review (SLR) was conducted, where 910 studies were retrieved manually in five...
Journal Articles
Iranian firms in biopharmaceutical value chain: where to go now?
Available to Purchase
Journal of Science and Technology Policy Management (2020) 11 (1): 49–63.
Published: 19 June 2019
...Masoud Afshari-Mofrad; Ali Salim Purpose Motivated by the huge potential of biosimilars in the near future and rapid growth of Iranian biosimilar producing firms in recent two decades, this paper aims to explore the positioning of these firms in biopharmaceutical value chain and their path...
